COMMONWEALTH EQUITY SERVICES, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$194,000
+43.7%
30,014
+1.7%
0.00%
Q2 2022$135,000
-43.3%
29,514
+7.1%
0.00%
-100.0%
Q1 2022$238,000
-38.3%
27,564
+1.7%
0.00%0.0%
Q4 2021$386,000
-35.1%
27,1000.0%0.00%0.0%
Q3 2021$595,000
+66.7%
27,100
+1.5%
0.00%0.0%
Q2 2021$357,000
+31.7%
26,7000.0%0.00%0.0%
Q1 2021$271,00026,7000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders